Topchoice Medical Co Inc
SSE:600763
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Topchoice Medical Co Inc
SSE:600763
|
CN |
|
B
|
Berry Global Group Inc
SWB:BP0
|
US |
|
KK Seiyoken
TSE:9734
|
JP |
|
LENSAR Inc
NASDAQ:LNSR
|
US |
|
T
|
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SGX:T14
|
CN |
|
W
|
Whirlpool SA
BOVESPA:WHRL3
|
BR |
|
BCE Inc
TSX:BCE
|
CA |
|
B
|
Beneficient
NASDAQ:BENF
|
US |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
M
|
Mooreast Holdings Ltd
SGX:1V3
|
SG |
Wall Street
Price Targets
Price Targets Summary
Topchoice Medical Co Inc
According to Wall Street analysts, the average 1-year price target for
Topchoice Medical Co Inc
is 48.05 CNY
with a low forecast of 30.3 CNY and a high forecast of 57.06 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Topchoice Medical Co Inc's stock price target?
Price Target
48.05
CNY
According to Wall Street analysts, the average 1-year price target for
Topchoice Medical Co Inc
is 48.05 CNY
with a low forecast of 30.3 CNY and a high forecast of 57.06 CNY.
What is Topchoice Medical Co Inc's Revenue forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Topchoice Medical Co Inc's revenue is
19%.
The projected
CAGR
for the next 4 years is
17%.
What is Topchoice Medical Co Inc's Operating Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Topchoice Medical Co Inc's operating income is
16%.
The projected
CAGR
for the next 3 years is
10%.
What is Topchoice Medical Co Inc's Net Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Topchoice Medical Co Inc's net income is
16%.
The projected
CAGR
for the next 3 years is
10%.
